Concepedia
Statistics
Publications
16
Citations
2.1K
H-Index
14
Active since
1985
Affiliations
Boehringer Ingelheim (United States)(Current)
Boehringer Ingelheim (Germany)
Boehringer Ingelheim (Canada)
Hospital Universitario Puerta de Hierro Majadahonda
Amsterdam UMC Location University of Amsterdam
Chan‐Loi Yong is an author at Boehringer Ingelheim (United States) specializing in medicine, virology, and hepatitis.
Top concepts
MedicineVirologyHepatitisPharmacologyViral HepatitisHivHepatologyHepatitis CNeurovirologyPharmacotherapy
Publications per year
1985–2014
An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus
Daniel Lamarre, Paul C. Anderson, Murray D. Bailey et al. · Nature · 2003 · 911 citations
Antiviral Effects, Hepatology, Hepatitis C Virus +9
Short-term antiviral efficacy of BILN 2061, a hepatitis C virus serine protease inhibitor, in hepatitis C genotype 1 patients
Holger Hinrichsen, Yves Benhamou, Heiner Wedemeyer et al. · Gastroenterology · 2004 · 331 citations · Full text
Hepatology, Hepatitis C, Viral Hepatitis +8
Anti-Inflammatory Effects of a p38 Mitogen-Activated Protein Kinase Inhibitor During Human Endotoxemia
Judith Branger, Bernt van den Blink, Sebastiaan Weijer et al. · The Journal of Immunology · 2002 · 232 citations · Full text
Antiviral efficacy of NS3‐serine protease inhibitor BILN‐2061 in patients with chronic genotype 2 and 3 hepatitis C†‡
Markus Reiser, Holger Hinrichsen, Yves Benhamou et al. · Hepatology · 2005 · 175 citations · Full text
Potency, safety, and pharmacokinetics of the NS3/4A protease inhibitor BI201335 in patients with chronic HCV genotype-1 infection
Michael P. Manns, Marc Bourlière, Yves Benhamou et al. · Journal of Hepatology · 2010 · 112 citations
Viral Hepatitis, Antiviral Drug Development, Antiviral Therapy +6
1–5 of 16